Who are Averywell's investors?

Averywell's investors include Genesis Ventures.

Averywell

1 known investors

Find your way into Averywell

Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.

AI & Machine Learning Biotech Healthtech

Investors · 1

Genesis VenturesAthens · $108K – $432K

Funding

SEC filings, press & company announcements

Undisclosed amountpre-seed funding roundApr 2024
Genesis Ventures (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Averywell Secures Genesis Ventures Investment: Pioneering Lung Cancer Detection with MiRNA Tech - Averywellaverywell.com · Apr 2024

Why We Invested In Averywell-microRNA liquid biopsy for the screening of lung cancer | by Thanasi Tsiodras | Genesis Ventures Blog | Mediummedium.com · Apr 2024

Frequently asked questions

What does Averywell do?: Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.
Who are Averywell's investors?: Averywell's investors include Genesis Ventures.